首页> 美国卫生研究院文献>Annals of Intensive Care >ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU
【2h】

ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU

机译:ICG肝脏测试与新的生物标志物作为重症患者延长住院时间的预后指标-预测ICU住院时间准确性的前瞻性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPrognostic abilities of medical parameters, which are scoring systems, measurements and biomarkers, are important for stratifying critically ill patients. Indocyanine green plasma disappearance (ICG-PDR) is an established clinical tool for the assessment of liver perfusion and function. Copeptin, MR-proANP and pro-ADM are biomarkers whose prognostic value is still unclear. The goal of this prospective study was to evaluate ICG-PDR, copeptin, MR-proANP and pro-ADM to predict prolonged length of stay (pLOS) in the ICU.
机译:背景医学参数的预后能力是评分系统,测量和生物标志物,对重症患者进行分层很重要。吲哚菁绿色血浆消失(ICG-PDR)是用于评估肝灌注和功能的成熟临床工具。 Copeptin,MR-proANP和pro-ADM是生物标志物,其预后价值尚不清楚。这项前瞻性研究的目的是评估ICG-PDR,copeptin,MR-proANP和pro-ADM,以预测ICU的长期住院时间(pLOS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号